Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with ⁹⁰Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI

Table 1

Patient characteristics.

Characteristic	Patients ()
Age, years
Mean (SD)	59.2 (9.9)
Median	61
Gender, number of patients
Male	10
Female	10
Primary tumor site, number of patients
Small bowel	10
Pancreas	8
Lung	1
Unknown	1
Histology, number of patients
G1/G2	14
G3	2
Unknown	4
Treatment, number of patients
Only ^90Y-DOTATOC	17
Switch to ^177Lu-DOTATOC in second therapy session	3